Testing effectiveness (Phase 2)Study completedNCT01756716
What this trial is testing
Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR
Who this might be right for
Diabetic Nephropathy
Tanabe Pharma Corporation 49